2024
DOI: 10.3390/biomedicines12050941
|View full text |Cite
|
Sign up to set email alerts
|

Signatures and Discriminative Abilities of Multi-Omics between States of Cognitive Decline

Filippos Anagnostakis,
Michail Kokkorakis,
Keenan A. Walker
et al.

Abstract: Dementia poses a substantial global health challenge, warranting an exploration of its intricate pathophysiological mechanisms and potential intervention targets. Leveraging multi-omic technology, this study utilizes data from 2251 participants to construct classification models using lipidomic, gut metabolomic, and cerebrospinal fluid (CSF) proteomic markers to distinguish between the states of cognitive decline, namely, the cognitively unimpaired state, mild cognitive impairment, and dementia. The analysis i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…Early detection and intervention in neurocognitive disorders are paramount for improving patient outcomes. Predictive models that can accurately identify individuals at risk for progressing from mild NCD to major NCD are crucial for implementing timely interventions that can slow cognitive decline [ 14 ]. Recent advancements have demonstrated the transformative impact of artificial intelligence (AI)-based techniques in early detection and diagnosis, emphasizing the potential of these tools in clinical settings [ 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…Early detection and intervention in neurocognitive disorders are paramount for improving patient outcomes. Predictive models that can accurately identify individuals at risk for progressing from mild NCD to major NCD are crucial for implementing timely interventions that can slow cognitive decline [ 14 ]. Recent advancements have demonstrated the transformative impact of artificial intelligence (AI)-based techniques in early detection and diagnosis, emphasizing the potential of these tools in clinical settings [ 15 , 16 ].…”
Section: Introductionmentioning
confidence: 99%